PTCA in the elderly: the "young-old" versus the "old-old"

Area of Science:

• Cardiology
• Geriatric Medicine
• Interventional Cardiology

Background:

• Coronary artery disease (CAD) is a significant health concern in the elderly population.
• Percutaneous transluminal coronary angioplasty (PTCA) is a common intervention for CAD.
• The safety and efficacy of PTCA in very elderly patients require further evaluation.

Purpose of the Study:

• To assess the outcomes of PTCA in patients aged 60 years and older with CAD.
• To compare clinical parameters and outcomes across different age strata within the elderly population.
• To determine if advanced age is a contraindication for PTCA.

Main Methods:

• Prospective study of 907 consecutive elderly patients (≥60 years) undergoing de novo PTCA.
• Analysis of patient risk factors, disease characteristics, and clinical outcomes with at least 3-year follow-up.
• Stratification into age groups: 60-69, 70-79, and 80+ years.

Main Results:

• Procedural success rates for PTCA were similar across all age groups.
• While overall complications increased with age, critical complications (MI, reocclusion, death) did not.
• Older patients had a higher prevalence of multi-vessel disease and longer hospital stays, but long-term outcomes were comparable.
• Female predominance and higher rates of congestive heart failure and prior myocardial infarction were noted in the oldest group (80+).

Conclusions:

• Advanced age is associated with specific risk factor and clinical parameter profiles in CAD patients.
• Age alone should not be a limiting factor in considering PTCA for elderly patients.
• PTCA remains a viable and effective treatment option for selected elderly individuals with CAD.